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SUMMARY

The p53-induced long noncoding RNA (lncRNA) lincRNA-p21 is proposed to act in cis to promote p53-dependent expression of the neighboring cell cycle gene, Cdkn1a/p21. The molecular mechanism through which
the transcribed lincRNA-p21 regulatory locus activates p21 expression remains poorly understood. To elucidate the functional elements of cis-regulation, we generate a series of genetic models that disrupt DNA
regulatory elements, the transcription of lincRNA-p21, or the accumulation of mature lincRNA-p21. Unexpectedly, we determine that full-length transcription, splicing, and accumulation of lincRNA-p21 are dispensable for the chromatin organization of the locus and for cis-regulation. Instead, we find that production of
lincRNA-p21 through conserved regions in exon 1 of lincRNA-p21 promotes cis-activation. These findings
demonstrate that the activation of nascent transcription from this lncRNA locus, but not the generation or
accumulation of a mature lncRNA transcript, is necessary to enact local gene expression control.

INTRODUCTION
The lncRNA lincRNA-p21, also known as Trp53cor1 (tumor protein p53 pathway co-repressor 1), is a 3.1-kb spliced, noncoding
transcript that is induced by the central tumor suppressor p53,
and it has been implicated in a range of processes, including
apoptosis, cell cycle control, and the hypoxia response (Dimitrova et al., 2014; Guttman et al., 2009; Huarte et al., 2010;
Yang et al., 2014). Despite its potential importance in mediating
p53 function, the roles and mechanisms of lincRNA-p21 remain
incompletely understood. On the one hand, a large number of
studies, using tools based on RNAi and exogenous overexpression, have ascribed lincRNA-p21 trans-regulatory functions
throughout the nucleus and in the cytoplasm via interactions
with various RNA-binding proteins, mRNAs, and microRNAs
(Ao et al., 2019; Huarte et al., 2010; Sun et al., 2019; Yang
et al., 2014; Yoon et al., 2012), and efforts have been dedicated
to determining how the lincRNA-p21 structure promotes these
activities (Chillón and Pyle, 2016). On the other hand, two independent genetic deletion studies have revealed a more restricted
role for lincRNA-p21 as a local transcriptional co-activator of its
neighboring gene, p21, also known as Cdkn1a (cyclin-dependent kinase inhibitor 1a) (Dimitrova et al., 2014; Groff et al.,
2016). Consistent with its role as a cis-regulator, lincRNA-p21
has been shown to accumulate at its site of transcription and
to be expressed at low copy number (Dimitrova et al., 2014).
However, it has remained unclear whether the RNA, its transcription, or enhancer-like DNA elements in the locus are the primary

mediators of lincRNA-p21 cis-regulatory activities (Allen et al.,
2014; Groff et al., 2016; Korkmaz et al., 2016). Indeed, while
several lncRNAs have emerged as functional modulators of local
epigenetic state (Blank-Giwojna et al., 2019; Kotzin et al., 2016;
Nagano et al., 2008; Strehle and Guttman, 2020), other transcribed cis-regulatory loci have been shown to act through overlapping transcription or enhancer elements rather than regulatory lncRNAs (Alexanian et al., 2017; Anderson et al., 2016;
Engreitz et al., 2016; Isoda et al., 2017; Latos et al., 2012; Paralkar et al., 2016).
Here, we develop a series of genetic tools to dissociate the
lincRNA-p21 transcript and transcriptional process from the underlying DNA regulatory sequences and to determine the key elements required for its cis-regulatory activity. Our data highlight
the power of complementary genetic approaches to resolve the
functional elements in lncRNA loci and reveal a role for transcription of nascent lincRNA-p21 from conserved DNA elements in
enacting activation of local gene expression.
RESULTS
p53 cooperatively regulates lincRNA-p21 and p21
through proximal and distal p53 response elements
As previously shown, lincRNA-p21 and p21 are divergent transcripts expressed approximately 12 kb apart and co-activated
by the transcription factor p53. In response to stress, such as
upon passaging of primary mouse embryonic fibroblasts (MEFs)
or following treatment with the DNA damage-inducing agent
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doxorubicin (Doxo), p53 binds to conserved p53 response elements (p53REs) located in the promoters of lincRNA-p21 (RE)
and p21 (RE1 and RE2) (Figure 1A). As expected, CRISPR-Cas9
mutagenesis of RE led to a 75% decrease in lincRNA-p21 levels,
confirming its direct regulation by p53 (Figure 1B) (Huarte et al.,
2010). Consistent with a previously proposed role for lincRNAp21 in promoting p21 expression (Dimitrova et al., 2014), RE mutagenesis correlated with an approximately 25%–40% decrease in
p21 RNA and protein levels (Figures 1B and 1C). To further characterize the interplay between the two genes, we performed chromosome conformation capture (3C) analysis of the lincRNA-p21/
p21 locus. We observed a strong interaction between the regions
containing the lincRNA-p21 and p21-associated p53REs, suggesting that the three p53REs may act cooperatively to regulate
p21 expression (Figure 1A). Interestingly, the chromatin looping
appeared to be constitutive and independent of p53 status or
the stress response (Figures 1A and S1). Consistent with a cooperative interaction between the p53REs, CRISPR-Cas9 mutagenesis of RE1 and RE2 also affected the expression of both p21 and
lincRNA-p21 (Figures 1D and 1E). The spatial proximity and functional cooperativity between the three p53REs raised the question
of whether lincRNA-p21 transcription and/or transcript accumulation contribute to p21 regulation or are nonfunctional by-products
of p53 transcriptional activity.

lincRNA-p21 exon- and intron-specific signals by single molecule RNA-FISH (smRNA-FISH), lincRNA-p21-specific signals
were largely absent from mutant cells (Figure 2D).
Next, we evaluated the extent to which PAS and TWI insertions
affected total lincRNA-p21 in steady-state RNA isolated from
Doxo-treated MEFs. Using primers specific to regions both upstream and downstream of the insertion site in exon 1, we
observed significant depletion of lincRNA-p21 in lincRNAp21PAS/PAS and lincRNA-p21TWI/TWI cells compared to wildtype controls (Figure 2E). Notably, the PAS and TWI mutations
led to a comparable reduction of lincRNA-p21 levels (Figure 2E).
To distinguish whether the TWI insertion led to post-transcriptional degradation of lincRNA-p21 or affected lincRNA-p21
biogenesis, we performed transient transcriptome (TT) analysis
of s4U-labeled RNA. Primers located in exon 1 both upstream
and downstream of the TWI insertion site revealed that TWI led
to the degradation of 60%–80% of newly transcribed lincRNAp21, while primers located in exon 2 approximately 20 kb downstream of the TWI insertion pointed to a 90% reduction in
transcription near the transcription termination site (Figure 2F).
These results indicated that the PAS led to efficient transcription
termination, while TWI mediated co-transcriptional transcript
degradation and only allowed approximately 10% of full-length
transcript production.

Development of genetic models to query the role of
lincRNA-p21 transcription and transcript accumulation
To investigate RNA-dependent contributions of the lincRNA-p21
locus to p21 regulation, we generated two independent genetic
models. To determine whether transcription through the
lincRNA-p21 locus is required for p21 activation, we used
CRISPR-Cas9-mediated genetic engineering to insert the
49-nucleotide synthetic polyadenylation signal (PAS) (Levitt
et al., 1989) into exon 1 of the endogenous lincRNA-p21 locus
in murine blastocysts (Figure 2A). In parallel, to determine the
contribution of the lincRNA-p21 RNA to p21 regulation, we introduced the 74-nucleotide Twister (TWI) self-cleaving ribozyme
(Roth et al., 2014) at the same site in exon 1 of endogenous murine lincRNA-p21 (Figure 2A). We anticipated that while the PAS
element would lead to premature termination, TWI would allow
transcription of lincRNA-p21 but lead to transcript cleavage
and degradation. LincRNA-p21PAS and lincRNA-p21TWI founder
animals were crossed to C57BL/6J mice to obtain germline
transmission (Figures S2A and S2B). Next, heterozygous
crosses revealed that mice harboring homozygous PAS and
TWI lincRNA-p21 alleles are viable, born at Mendelian ratios,
and do not display any apparent abnormalities, consistent with
previous lincRNA-p21 knockout models (Figure S2C) (Dimitrova
et al., 2014; Sauvageau et al., 2013).
To determine the effects of the PAS and TWI insertion on
lincRNA-p21 expression, we first analyzed the levels of mature,
spliced lincRNA-p21 in total RNA isolated from E13.5 MEFs in
the absence or presence of Doxo. While wild-type MEFs displayed the expected 3- to 5-fold induction of lincRNA-p21
upon Doxo treatment, lincRNA-p21 was undetectable in
lincRNA-p21PAS/PAS and lincRNA-p21TWI/TWI cells isolated from
littermate embryos (Figures 2B and 2C). Consistently, while control cells exhibited the typical 2- to 4-dot pattern of overlapping

Mature lincRNA-p21 production and accumulation are
dispensable for p21 regulation
With these validated tools in hand, we next queried how inhibition of lincRNA-p21 transcription and transcript accumulation
affect p21 expression. In contrast to previous lincRNA-p21 promoter and locus genetic deletion models (Dimitrova et al., 2014;
Groff et al., 2016), we found that the levels of p21 in lincRNAp21PAS/PAS and lincRNA-p21TWI/TWI cells did not differ significantly from wild-type MEFs in either the absence or presence
of DNA damage (Figures 3A and 3B). Moreover, there was no
difference in p21 protein levels (Figures 3C and 3D), and
lincRNA-p21PAS/PAS and lincRNA-p21TWI/TWI cells proliferated
at comparable rates as littermate controls, indicating normal
cell cycle progression (Figures 3E and 3F). We concluded that
the production and accumulation of mature lincRNA-p21 are
dispensable for the regulation of p21.
These findings conflicted with previous data, in which antisense oligonucleotide (ASO)-mediated knockdown lincRNAp21 led to a reduction of p21 expression and implicated
lincRNA-p21 production or transcript in cis-regulation (Dimitrova
et al., 2014). To address the inconsistency, we introduced the
published (Dimitrova et al., 2014) lincRNA-p21-targeting ASO1
(A1) and ASO3 (A3) in wild-type MEFs as well as in littermate
lincRNA-p21PAS/PAS and lincRNA-p21TWI/TWI cells. Both A1 and
A3 led to greater than 90% knockdown of lincRNA-p21 in wildtype MEFs, whereas lincRNA-p21 levels were undetectable in
both control (Con)-, A1-, and A3-treated PAS and TWI cells (Figure 3G). Strikingly, we observed that introduction of A1 and A3
led to comparable reductions of p21 levels regardless of genotype, indicating that the ASOs were not acting through knockdown of lincRNA-p21 (Figure 3H). We concluded that the
lincRNA-p21-targeting ASOs affected p21 expression levels
through a lincRNA-p21-independent mechanism.
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Figure 1. Reciprocal regulation of lincRNA-p21 and p21 by proximal and distal p53 response elements
(A) Top, 3C analysis showing interaction frequency relative to genomic position, n = 3; Bottom, schematic of the lincRNA-p21/p21 locus highlighting the locations
of the p53REs (*) and 3C anchor position (red arrow).
(B) qRT-PCR of normalized spliced (ex.1/2) and nascent (ex.1 and ex.1/int) lincRNA-p21 and p21 levels in RNA from wild-type MEFs with indicated treatments,
n = 9.
(C) Top, representative immunoblot of p21 protein levels in whole cell lysates from MEFs in (B). Hsp90, loading control. Bottom, quantification of normalized p21
protein levels, n = 3.
(D and E) qRT-PCR of normalized lincRNA-p21 (D) and p21 (E) levels in RNA from MEFs, expressing Con or p53RE-targeting gRNAs, n = 3.
Data are represented as mean ± SEM of indicated biological replicates. Numbers indicate the percentage change relative to control samples with corresponding
treatment; n.s. not significant, **p < 0.01, ***p < 0.001; paired t test.
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Figure 2. Development of genetic tools to probe the contribution of lincRNA-p21 transcription and accumulation to p21 regulation
(A) Top, schematic of the lincRNA-p21 locus highlighting the PAS and TWI insertion site in exon 1. Bottom, littermate mutant and wild-type (WT) MEFs were
isolated at E13.5.
(B and C) qRT-PCR showing normalized spliced lincRNA-p21 levels in RNA from WT and lincRNA-p21PAS/PAS (B, n = 6) and lincRNA-p21TWI/TWI (C, n = 7)
MEFs, treated as indicated.
(D) smRNA-FISH images and quantification of signals using probes detecting lincRNA-p21 exons (red) and intron (green) in etoposide-treated MEFs. DNA
counterstained with DAPI in merged images.
(E) qRT-PCR of relative steady-state lincRNA-p21 levels in total DNAse-treated RNA from Doxo-treated MEFs, n = 4.
(F) Transient transcriptome (TT) qRT-PCR analysis of normalized lincRNA-p21 levels in s4U-labeled RNA from Doxo-treated MEFs.
Data are represented as mean ± SEM of indicated biological replicates; n.s. not significant, ***p < 0.001; paired t test.

A conserved element in exon 1 of lincRNA-p21 is
required for p21 activation
We were intrigued that p53-dependent production of lincRNAp21 may be entirely dispensable for cis-regulation. To search
for functional elements in the lincRNA-p21 locus beyond RE,
we engineered two mouse strains with deletions in exon 1 of
lincRNA-p21 (Figures S2D and S2E). D127 comprises a
127-nucleotide deletion, which includes a highly conserved region of exon 1 but leaves the p53RE intact (Figures 4A and
S2F). D151 targets a downstream region of exon 1 and includes
the 50 -splice site of the lincRNA-p21 intron (Figures 4A and S2F).
Analysis of RNA from primary MEFs isolated from lincRNAp21D127/D127, lincRNA-p21D151/D151, and corresponding wildtype littermate embryos revealed that both deletions led to a
complete loss of spliced lincRNA-p21 (Figure 4B). Interestingly,
while the D151 mutation did not affect p21 expression, indicating
that correct splicing is not required for cis-regulation, D127 led to
a significant decrease in p21 expression in both the absence and
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in the presence of Doxo-induced DNA damage (Figure 4C). We
also observed diminished p21 protein levels in lincRNAp21D127/D127 MEFs compared to controls (Figure 4D). Consequently, lincRNA-p21D127/D127 cells proliferated faster than
wild-type cells, consistent with a role for p21 in inhibiting cell cycle progression (Figure 4E). The changes in p21 levels were not
due to altered chromatin organization in the locus or diminished
p53 binding in the p21 promoter (Figures S3A–S3C). These findings pointed to a p53RE-independent element in the lincRNAp21 locus, which contributes to p21 regulation.
Nascent lincRNA-p21 transcription promotes p21
expression
To determine whether transcription through the novel element
played a role, we performed transcriptional interference using
CRISPR-Cas9. 15-nucleotide ‘‘dead’’ RNA (dRNAs) have been
shown to effectively recruit Cas9 and cause transcriptional interference without supporting Cas9 endonuclease activity
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Figure 3. lincRNA-p21 transcription and accumulation are dispensable for p21 regulation
(A and B) qRT-PCR of normalized p21 levels in RNA from indicated MEFs, n = 12 (A); n = 7 (B).
(C and D) Representative immunoblot images of p21 and p53 protein levels in whole cell lysates from MEFs in (A) and (B); Hsp90, loading control. n = 7 (C) and n = 8 (D).
(E and F) Growth curve showing population doublings of indicated MEFs over passages, n = 3.
(G and H) qRT-PCR of normalized lincRNA-p21 (H) and p21 (I) levels in RNA from indicated MEFs transfected with control (Con) or lincRNA-p21-targeting ASOs
(ASO1 and ASO3), n = 3.
Data are represented as mean ± SEM of indicated biological replicates; n.s. not significant, *p < 0.05, **p < 0.01, ***p < 0.001; paired t test. Numbers indicate
percentage change relative to controls with corresponding treatment.

(Dahlman et al., 2015). We designed two dRNAs, d2 and d3,
located upstream and downstream of RE, respectively, to interfere with transcription of lincRNA-p21 (Figure 4F). As a positive
control, we introduced a dRNA (d1), targeting the p53RE designed to obstruct p53 binding through steric hindrance (Figure 4F). As a negative control, we introduced a non-targeting
dRNA (dCon). We confirmed that the introduction of d1, d2,
and d3 in wild-type MEFs led to efficient downregulation of
nascent lincRNA-p21 compared to dCon (Figure 4G). Furthermore, we observed that all three dRNAs led to significant decreases in p21 levels (reduction by 28% ± 8%, 21% ± 6%, and
30% ± 2% by d1, d2, and d3, respectively, compared to dCon;
Figure 4H). Importantly, the effects of dRNA-mediated transcriptional interference on p21 levels were comparable to the p21 decreases observed with RE (reduction by 30% ± 4%; Figure 1D)
and D127 (reduction by 29% ± 4%; Figure 4C) mutations. These
findings indicated that transcription from the lincRNA-p21 locus

is important for cis-activation of p21. We concluded that cooperative activity of proximal and distal p53REs combined with p53dependent activation of lincRNA-p21 transcription are both
required for full activation of p21 expression (Figure 4I).
DISCUSSION
Despite growing knowledge of the context-specific expression
patterns and roles of lncRNAs in widespread homeostatic and
disease processes, the functional elements within lncRNAs
remain poorly understood (Kopp and Mendell, 2018). In this
study, we engineered a series of genetic tools to dissect the
functional elements of the well-characterized, cis-regulatory
lincRNA-p21 locus. Strikingly, we found that transcription, processing, and accumulation of full-length lincRNA-p21 are
dispensable for its role in promoting p21 expression. Given these
conclusions, previous functional and structural studies of the
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Figure 4. Nascent transcription of lincRNA-p21 promotes p21 expression
(A) Top, schematic highlighting the regions of D127 (red) and D151 (light red) deletions in lincRNA-p21. Bottom, littermate mutant and wild-type (WT) MEFs were
isolated at E13.5.
(B and C) qRT-PCR of normalized lincRNA-p21 (B) and p21 (C) levels in RNA from indicated MEFs, n = 3–8.
(D) Representative immunoblot image of p21 and p53 protein levels in whole cell lysates from MEFs in (C); Hsp90, loading control; n = 6.
(E) Growth curve showing population doublings of indicated MEFs over passages, n = 3.
(F) Schematic showing the location of dRNAs for transcriptional interference.
(G and H) qRT-PCR of normalized nascent lincRNA-p21 (G) and p21 (H) RNA levels in total DNAse-treated RNA isolated from WT MEFs expressing indicated
dRNAs.
(I) Left, model depicting the cooperative regulation of lincRNA-p21 and p21 expression by proximal and distal p53REs. Right, models for the proposed
contribution of nascent lincRNA-p21 in the recruitment of RNA-binding proteins (RBP) or DNA-binding proteins (DBP), which may directly regulate p21 expression
due to looped chromatin architecture of the lincRNA-p21/p21 locus.
Data are represented as mean ± SEM of indicated biological replicates; n.s. not significant, *p < 0.05, **p < 0.01, ***p < 0.001, n = 3, paired t test. Numbers indicate
the percentage change relative to controls with corresponding treatment.
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full-length lincRNA-p21 transcript should be re-evaluated, and
findings should be replicated in the context of these novel genetic models. Our findings support the conclusions from previous studies, which observed a lack of correlation between
mature lincRNA-p21 and p21 expression levels and identified
an enhancer-like regulatory element in the lincRNA-p21 promoter (Allen et al., 2014; Groff et al., 2016; Korkmaz et al.,
2016). Notably, our observations are at odds with previous
work, which used lincRNA-p21-targeting ASOs to establish a
role for lincRNA-p21 production in p21 regulation (Dimitrova
et al., 2014). Our findings of off-target effects caution against
the use of ASOs as a sole method for determining a role for a
lncRNA transcriptional process or transcript (Lai et al., 2020;
Lee and Mendell, 2020).
Here, we establish that p53 acts cooperatively through
lincRNA-p21- and p21-associated proximal and distal
p53REs to regulate the expression of the two neighboring
genes during the cellular response to stress (Figure 4I, left).
This is aided by the constitutively looped chromatin architecture of the locus, which brings the p53REs within spatial
proximity. Surprisingly, we find that full-length lincRNA-p21
production, processing, and transcript accumulation are
dispensable for cis-regulation, suggesting that lincRNA-p21
may be a nonfunctional by-product of p53 transcriptional activity. However, we found evidence that nascent lincRNA-p21
transcription reinforces p21 expression independently of p53
binding. We envision two possible functions for lincRNA-p21
transcripts (Figure 4I, right). On the one hand, nascent
lincRNA-p21 may serve to directly recruit RNA-binding
proteins, such as hnRNP-K, which has previously been found
to interact with lincRNA-p21 and to play a role in stimulating
p21 expression (Dimitrova et al., 2014; Huarte et al., 2010).
Since nascent transcripts are physically tethered to the locus,
they are therefore perfectly positioned to act as local
recruitment platforms, even at low copy number (Davidovich
and Cech, 2015; Sigova et al., 2015). On the other hand,
transcription has been suggested to play a role in epigenetic
remodeling and ‘‘licensing’’ of distal enhancer elements (Anderson et al., 2016; Engreitz et al., 2016; Kaikkonen et al.,
2013; Scruggs et al., 2015). It is therefore conceivable that transcription through DNA elements in the lincRNA-p21 locus may
stimulate the recruitment of DNA-binding proteins and transcription factors, such as CEBPa/b and Sp1, which may in
turn directly affect p21 expression given the looped threedimensional architecture of the locus. Importantly, our findings
determine that nascent transcripts, and not full-length spliced
RNA molecules, are the functional elements of cis-regulation
in the locus.
Several previous studies have employed genetic approaches, such as PAS and polyadenylation cassette insertions, to interrogate the importance of mature lncRNA molecules (Engreitz et al., 2016; Isoda et al., 2017; Latos et al.,
2012; Paralkar et al., 2016). Many of these studies identified
DNA elements in lncRNA loci or various aspects of lncRNA
biogenesis, such as splicing or the act of transcription through
the loci as responsible for cis-activation. Our work identifies
nascent transcription as an additional functional player in cisregulation and highlights the need to use multiple complemen-

OPEN ACCESS

tary genetic approaches to dissect the functional elements of
regulatory lncRNA loci.
Limitations of the study
The present study does not provide insights into the functional
features of nascent lincRNA-p21 transcripts, such as their
length, stability, and PolII association. Moreover, the importance
of the nascent RNA transcripts themselves versus the process of
nascent transcript production remains to be elucidated.
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Pen-strep
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GIBCO
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2-mercaptoethanol

GIBCO

Cat#21985023

SYBR Fast Master Mix

Kapa Biosystems
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Invitrogen

Cat#15-596-018

RNasin Plus RNase inhibitor

Promega

Cat#N2615

QuantiTect Probe PCR Master Mix

Qiagen

Cat#204343

Nitrocellulose membranes

Bio-Rad

Cat#1620112

ECL Prime Western Blotting detection reagent

GE Healthcare

Cat#RPN2232

Methanol-free formaldehyde

ThermoScientific
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Formamide

Millipore Sigma
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Stellaris_ RNA FISH Hybridization Buffer

LGC Biosciences
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Stellaris_ RNA FISH Wash Buffer A

LGC Biosciences

Cat#SMF-WA1-60

Stellaris_ RNA FISH Wash Buffer B

LGC Biosciences

Cat#SMF-WB1-20

VECTASHIELD_ Antifade
Mounting Medium with DAPI

Vector Laboratories

Cat#H-1200

Stellaris FISH Probes, Custom
Assay with Quasar 670 Dye

LGC Biosciences

Cat#SMF-1065-5

Stellaris FISH Probes, Custom
Assay with Quasar 570 Dye

LGC Biosciences

Cat#SMF-1063-5

cOmplete, Mini Protease Inhibitor Cocktail

Roche

Cat#4693124001

PureProteome Protein G Magnetic Beads

Millipore Sigma

Cat#LSKMAGG02

Salmon Sperm DNA

Invitrogen

Cat#15632011
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Proteinase K
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NEBufferTM 3.1
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This study
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qRT-PCR primers, see Table S1
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PCR primers, see Table S1

This study
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smRNA FISH probes

Dimitrova et al., 2014

N/A

3C qPCR primers, see Table S1

This study

N/A

3C Taqman probe, see Table S1

This study

N/A

Mouse: lincRNA-p21

Oligonucleotides

ChIP qPCR primers, see Table S1

This study

N/A

gRNA sequences, see Table S1

This study

N/A

dRNA sequences, see Table S1

This study

N/A

HDR templates, see Table S1

This study
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Dimitrova et al., 2014
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GraphPad Prism, version 7.01 for Windows
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https://www.graphpad.com

Biorender
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https://www.biorender.com

Recombinant DNA

Software and algorithms
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Dimitrova (nadya.dimitrova@yale.edu).
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Materials availability
Mouse lines and reagents generated in this study are available from the Lead contact with a completed Materials Transfer
Agreement.
Data and code availability
All data reported in this paper will be shared by the Lead contact upon request. This paper does not report original code. Any additional information required to reanalyze the data reported in this paper is available from the Lead contactupon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse strains
LincRNA-p21 edited mice were generated using CRISPR/Cas9-mediated engineering in C57BL/6J blastocysts at the Jackson Laboratory for Genomic Medicine. Briefly, embryos were electroporated with Cas9, a guide RNA targeting lincRNA-p21 and PAS and
TWI HDR templates, described in Table S1. Founders were crossed to wild-type C57BL/6J mice. Germline transmission was identified by PCR genotyping using primers described in Table S1. Correct alleles were confirmed by Sanger sequencing. The two deletion alleles (D127 and D 151) were fortuitously identified in the founder population and confirmed by Sanger sequencing. To determine
viability and normal development, mice with equal sex distribution were aged up to six months. All studies and procedures were conducted with the approval of the Yale University Institutional Animal Care and Use Committee.
Cell culture and drug treatments
Primary MEFs were isolated from E13.5 embryos resulting from timed matings between 3-6 month-old male and female mice heterozygous for the lincRNA-p21 allele of interest. All experiments were performed with littermate wild-type (WT) and mutant MEFs
between passages 2 and 8. Primary MEFs were maintained in DMEM (Gibco) supplemented with 15% fetal bovine serum (FBS),
50 U mL1 penicillin-streptomycin, 2 mM L-glutamine, 0.1 mM non-essential amino acids, and 0.055 mM b-mercaptoethanol. All cells
were maintained at 37 C in a humidified incubator with 5% CO2. To induce DNA damage, MEFs were treated with 0.5 mM doxorubicin
(Doxo, Sigma-Aldrich) for RNA, protein, and chromatin analyses or 25 mM etoposide (Sigma-Aldrich) for smRNA-FISH studies. ASO
studies were performed as described in (Dimitrova et al., 2014).
Constructs
p53RE mutagenesis (RE, RE1, and RE2) and transcriptional interference (d1, d2, and d3) were performed using gRNAs or dRNAs
cloned downstream of a U6 promoter in the spCas9-expressing BRD001 (lentiCRISPRv1) lentiviral construct (a gift from Feng Zhang,
Broad Institute, MIT). Control gRNA or dRNA targeting dTomato served as a negative control. All gRNA and dRNA sequences are
listed in Table S1.
METHOD DETAILS
Lentiviral infection
To generate lentivirus, HEK293 cells were co-transfected with pCMV-D8.2 (Addgene 8455) and pCMV-VSV-G (Addgene 8454), and
the indicated lentiviral construct. Virus-containing media, harvested at 48, 72, and 96 hours post-transfection and supplemented with
4 mg mL1 polybrene, was directly applied to MEFs. Following infection, MEFs were selected with 2 mg mL1 puromycin for 72 hours.
Total RNA isolation and qPCR
Total RNA was isolated using RNeasy Mini (Qiagen) protocol with or without DNAse I digestion (Qiagen) and reverse-transcribed using the High Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems). For qPCR, SYBR Green Mastermix was used with
primers listed in Table S1. Expression levels were calculated relative to Gapdh and normalized to corresponding control samples.
Metabolically-labeled RNA isolation and analysis
MEFs, cultured in the absence or presence of Doxo, were treated with 1 mM 4-thiouridine (s4U, Alfa Aesar) for 5 minutes. Samples
were placed on ice, rinsed with PBS, harvested by scraping, suspended in TRIzol, and frozen at 80 C. Total RNA was isolated using
chloroform extraction and isopropanol precipitation and treated with TURBO DNase to deplete genomic DNA. Purified RNA was then
extracted using phenol-chloroform-isoamyl alcohol followed by ethanol precipitation. 50 mg of total RNA was biotinylated using
MTSEA biotin-XX (Biotium) and enriched using streptavidin as previously described (Schofield et al., 2018). The resulting nascent
RNA was reverse-transcribed using the SuperScript VILO cDNA Synthesis Kit (Thermo Fisher Scientific) and analyzed via qPCR using
iTaq Universal SYBR Green Supermix (Bio-Rad) with primers listed in Table S1. Levels of nascent transcripts were calculated relative
to Gapdh and normalized to WT, untreated sample.
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Western blotting
Whole cell lysates were prepared by resuspending cell pellets in 2x Laemmli buffer (100 mM Tris-HCl pH 6.8, 200 mM DTT, 3% SDS,
20% glycerol) at a concentration of 104 cells/mL. Samples were boiled at 95 C for 7 minutes and passed through an insulin syringe.
Protein samples from 105 cells were separated by electrophoresis on a SDS-polyacrylamide gel and transferred to a 0.2 mm nitrocellulose membrane. Immunoblotting was performed using the following antibodies: p21 (clone F-5, sc-6246, Santa Cruz Biotechnology), p53 (clone CM5, NCL-L-p53-CM5p, Leica), and loading control Hsp90 (clone C45G5, #4877S, Cell Signaling Technology).
Single molecule RNA fluorescence in situ hybridization (smRNA-FISH)
smRNA-FISH was performed as previously described (Dimitrova et al., 2014). Briefly, MEFs were seeded on coverslips and cultured
for 24 hours in the presence or absence of etoposide before being fixed in 4% methanol-free formaldehyde in DEPC-treated water for
10 minutes at room temperature. After being washed twice in PBS, cells were dehydrated overnight in 70% ethanol at 4 C and stored
for up to a week. Dehydrated coverslips were transferred to a hybridization chamber and equilibrated in Wash Buffer A for 5 minutes
(LGC, Biosearch Technologies). Samples were incubated overnight at 30 C in hybridization buffer containing a 1:50 dilution of Stellaris probes conjugated to Quasar 570 or Quasar 670 dye. The following day, samples were washed twice with Wash Buffer A for
30 minutes at 30 C, washed once with Wash Buffer B for 5 minutes at room temperature, and mounted in Vectashield Antifade
Mounting Medium with DAPI (Vector Laboratories). Samples were imaged using the Axio Imager 2 microscope system (Zeiss)
with a PlanApo 6331.4 oil DIC objective lens (Zeiss).
Chromosome conformation capture (3C)
3C was performed as previously described with slight modifications (Hagege et al., 2007; Naumova et al., 2012). Briefly, 5–10 3 106
cells were harvested by trypsinization, rinsed once in PBS, and resuspended in 1% methanol-free formaldehyde in PBS. Samples
were rotated end-over-end for 10 minutes at room temperature and quenched with ice-cold 2.5 M glycine. Following incubation
for 5 minutes at room temperature and on ice for 15 minutes, samples were spun down at 225 g for 8 minutes at 4 C and washed
once in ice-cold PBS. Samples were flash frozen and stored for up to six months at 80 C. For cell lysis, frozen samples were thawed
on ice and resuspended in 5 mL ice-cold Lysis buffer (20 mM Tris HCl pH 8.0, 85 mM KCl, 0.5% NP-40, and Mini Complete Protease
Inhibitor Cocktail Tablet (Roche)) for two hours. Samples were spun down at 400 g for 5 minutes at 4 C and resuspended in 0.5 mL
1.2X NEB Buffer 3.1 with 0.3% SDS. Next, samples were rotated end-over-end for 1 hour at 37 C, quenched with 2% Triton X-100,
and again rotated end-over-end for 1 hour at 37 C. For chromatin digestion, samples were treated with 400 U BglII (NEB) and rotated
end-over-end overnight at 37 C. To inactivate the restriction enzyme, the SDS concentration was increased to 1.6% and samples
were shaken at 900 rpm for 25 minutes at 65 C. Next, samples were diluted by adding 6.125 mL 1.15X ligation buffer (10X ligation
buffer: 600 mM Tris HCl pH 7.5, 50 mM DTT, 50 mM MgCl2, 10 mM ATP) and Triton X-100 to a final concentration of 1%. After incubating for 1 hour at 37 C with gentle shaking, 100 U of T4 DNA ligase (NEB) was added to each sample. All samples were incubated
for 4 hours at 16 C followed by 30 minutes at room temperature. To reverse the crosslinking, samples were treated with 300 mg Proteinase K and incubated overnight at 65 C with end-over-end rotation, followed by treatment with 300 mg RNAse A (Qiagen) for 45 minutes at 37 C. DNA was isolated using phenol-chloroform followed by ethanol precipitation. Purified DNA was resuspended in 10 mM
Tris pH 7.5. Digestion efficiency was determined by reversing the cross-linking of chromatin samples taken before and after BglII
digestion, followed by Proteinase K and RNAse-treatments, phenol-chloroform DNA purification, and ethanol precipitation. Purified
DNA was subjected to qPCR analysis using primer sets spanning BglII sites. Next, qPCR was used to determine the concentration of
each 3C library relative to a standard curve obtained by running serial dilutions of a control template. Libraries were diluted to a final
concentration of 50 ng mL1. Interaction frequencies relative to a control region in the lincRNA-p21 locus were measured by performing TaqMan qPCR on 50 ng 3C library using unidirectional primers in tandem with an anchor primer and fluorescent TaqMan probe
targeting the lincRNA-p21 promoter (Table S1).
Chromatin immunoprecipitation (ChIP)
To detect p53 and H3K27ac enrichment at p21 promoter, 5–10 3 106 MEFs were fixed in 1% methanol-free formaldehyde for 10 minutes at room temperature, quenched with 100 mM ice-cold glycine for five minutes on ice, washed twice in PBS, flash frozen, and
stored at 80 C. Nuclei were isolated by incubating the thawed cell pellet in Cell lysis buffer (20 mM Tris-HCl, pH 8.0, 85 mM KCl,
0.5% NP-40), supplemented with protease inhibitors (1 mM PMSF and Mini Complete Protease Inhibitor Cocktail Tablet (Roche)) on
ice for 10 min. After centrifugation, the supernatant was removed and the nuclei were resuspended in Nuclei lysis buffer (50 mM TrisHCl, pH 8.0, 10 mM EDTA, 1% SDS supplemented with protease inhibitors) and incubated for 10 min on ice. Next, chromatin was
sonicated to 300–500 bp fragment size for 5 cycles (1500 ON, 9000 OFF) at 4 C using a Bioruptor sonicator (Diagenode). Sonicated
lysates were centrifuged at 13, 000 rpm for 20 minutes and diluted in ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100,
1.1 mM EDTA, 20 mM Tris-HCl, pH 8.0, 167 mM NaCl, supplemented with protease inhibitors). Input aliquots were saved at this point.
Chromatin immunoprecipitations were set up with a p53 antibody (clone CM5, NCL-L-p53-CM5p, Leica), a H3K27ac antibody
(ab4729, Abcam), or control IgG (ab46540, Abcam), pre-conjugated to PureProteome Protein G Magnetic Beads (Millipore), blocked
with 0.5% BSA in PBS and supplemented with 20 mg salmon sperm DNA (Invitrogen). The immunoprecipitations were incubated
overnight at 4 C on a rotator. The next day, beads were washed once in each of the following washes for 5 minutes at 4 C on the
rotator: Low salt wash (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.0, 150 mM NaCl supplemented with protease
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inhibitors), High salt wash (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 500 mM NaCl), LiCl wash (0.25 M LiCl,
1% NP-40, 1% Na deoxycholate, 1 mM EDTA, 20 mM Tris-HCl, pH 8.0), and TE wash (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). After
completely removing any remaining liquid from the washes, beads were resuspended in Elution buffer (50 mM Tris-HCl, pH 8.0,
10 mM EDTA, pH 8.0, 1% SDS) and incubated at 65 C for 15 min with shaking to prevent settling of beads. After elution, the beads
were pelleted, and the supernatant was transferred to a new tube and incubated overnight at 65 C to reverse the crosslinking. The
next day, samples were treated with RNaseA for 2 hours at 37 C, followed by a Proteinase K treatment for 30 minutes at 55 C. The
DNA was purified by phenol-chloroform extraction and EtOH precipitation. The DNA pellet was air dried, resuspended in 200 mL H2O
and used for quantitative PCR analysis (ChIP-qPCR) using primers listed in Table S1.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data in figures are represented as mean ± SEM of biological replicates (n R 3); n.s. not significant, *p < 0.05, **p < 0.01, ***p < 0.001;
paired t test.
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